Choose Your Language:Chinese (Simplified) Chinese (Traditional) Danish Dutch English French German Italian Portuguese Spanish
August 10, 2022 – The Sumaira Foundation is pleased to welcome Dr. Sara Mariotto, neurologist at Azienda Ospedaliera Universitaria Integrata Verona (AOUI Verona), as the first member from Italy America to join TSF’s medical advisory board.
Sara Mariotto, MD, PhD, is a neurologist who works at the AOUI Verona, Italy where she is responsible for the diagnosis of NMOSD, MOGAD and autoimmune encephalitis and is the referring clinical consultant for neuroimmunological disorders.
In 2010, Dr. Mariotto graduated in medicine and surgery and specialized in neurology in 2016 at the University of Verona in Italy. In 2020, she completed a 3-year PhD at the Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona and also obtained the certificate of Doctor Europaeus. After her PhD, she was awarded an 8-month scholarship on the study of diagnostic and prognostic tests in antibody-mediated encephalitis and neuromyelitis optica.
Her principal field of interest is the study of autoimmune/inflammatory encephalitis, encephalomyelitis, NMOSD, MOGAD, and peripheral inflammatory neuropathies. In relation to these topics, she studied antibody-mediated CNS disorders during her fellowship at the Clinical Department of Neurology, Medical University of Innsbruck and at the Institute of Neurology, Medical University of Vienna.
She actively participates in clinical and research activities, collaborative study designs, and discussions about challenging national cases with CNS inflammatory and autoimmune conditions.
Recently, her research has focused on increasing the diagnostic sensitivity for NMOSD and MOGAD and the analysis of novel biomarkers of disease activity.
Dr. Mariotto has more than 100 peer-reviewed research articles/reviews, a member of the editorial boards of international journals and the associate editor of Immunologic Research, and is part of the International Clinical Consortium for the study of NMOSD, and of the Neuroimmunology Board of the European Academy of Neurology.